Company Analysis
Sign in

NervGen Pharma Corp. (NGEN)

Nasdaq: NGEN · Pharmaceutical Preparations · Vancouver, BC · filing with the SEC since 2018
Full chart Alerts Compare
Grade5.6
◀ Past 6.4● Present 4.0▶ Future 6.6
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In Canadian dollars (CAD), as filed; per-share figures in Canadian dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024
Period endingDec 31, 2025Dec 31, 2024
Report filedMar 31, 2026·
Research and development13,907,20615,811,020
General and administrative11,172,0469,365,129
Total operating expenses25,079,25225,176,149
Finance income333,415812,617
Net income-44,117,305-24,250,049
Earnings per share, basic-0.61-0.36
Earnings per share, diluted-0.61-0.36
Weighted average shares, basic72,330,90867,321,698
Weighted average shares, diluted72,330,90867,321,698
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherifrs-full:OperatingExpense
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton NGEN · research, not advice